US Patent 7317000 Glucose-dependent insulins
Patent 7317000 was granted and assigned to Novo Nordisk on January, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 27 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+293 characters)
Article
Patent abstract
The present invention relates to insulin derivatives having a built-in glucose sensor and a polyol moiety, capable to deliver insulin from an injected depot of an insulin derivative according to the invention as a function of the glucose concentration in the surrounding tissue.
Edits on 21 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07317000 Glucose-dependent insulins US Patent 7317000 Glucose-dependent insulins
Infobox
Patent Number
0731700000
Patent Number
731700000
Edits on 26 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073170000
Date of Patent
January 8, 2008
0Patent Application Number
103076780
Date Filed
December 2, 2002
0Official Website
Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073170000
Date of Patent
January 8, 2008
0Patent Application Number
103076780
Date Filed
December 2, 2002
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07317000 Glucose-dependent insulins
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07317000
Date of patent
January 8, 2008
Patent application number
10307678
Date Filed
December 2, 2002
Patent primary examiner
Find more entities like US Patent 7317000 Glucose-dependent insulins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.